603235 Stock Overview
Jiangxi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
JiangXi Tianxin Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.94 |
| 52 Week High | CN¥32.06 |
| 52 Week Low | CN¥19.13 |
| Beta | 0.51 |
| 1 Month Change | -9.57% |
| 3 Month Change | 5.56% |
| 1 Year Change | 15.67% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.28% |
Recent News & Updates
Recent updates
JiangXi Tianxin Pharmaceutical's (SHSE:603235) Earnings Are Built On Soft Foundations
Nov 05
We Think JiangXi Tianxin Pharmaceutical (SHSE:603235) Can Stay On Top Of Its Debt
Aug 23JiangXi Tianxin Pharmaceutical's (SHSE:603235) Weak Earnings May Only Reveal A Part Of The Whole Picture
May 06Does JiangXi Tianxin Pharmaceutical (SHSE:603235) Have A Healthy Balance Sheet?
Apr 24Shareholder Returns
| 603235 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 0.9% | -2.5% | -1.2% |
| 1Y | 15.7% | -4.7% | 11.8% |
Return vs Industry: 603235 exceeded the CN Personal Products industry which returned -4.7% over the past year.
Return vs Market: 603235 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility
| 603235 volatility | |
|---|---|
| 603235 Average Weekly Movement | 5.7% |
| Personal Products Industry Average Movement | 7.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603235 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603235's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 2,471 | Xiaobing Yua | www.txpharm.com |
Jiangxi Tianxin Pharmaceutical Co., Ltd. produces and sells vitamins in China. It offers products of vitamin B6, vitamin B9, folic acid, biotin, ascorbyl palmitate, and vitamin D3 for use as bulk pharmaceutical chemicals, food additives, and feed additives, as well as in other fields. The company was founded in 2004 and is based in Leping, China.
JiangXi Tianxin Pharmaceutical Co., Ltd. Fundamentals Summary
| 603235 fundamental statistics | |
|---|---|
| Market cap | CN¥11.75b |
| Earnings (TTM) | CN¥557.43m |
| Revenue (TTM) | CN¥2.01b |
21.1x
P/E Ratio5.8x
P/S RatioIs 603235 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603235 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.01b |
| Cost of Revenue | CN¥1.16b |
| Gross Profit | CN¥844.48m |
| Other Expenses | CN¥287.05m |
| Earnings | CN¥557.43m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.28 |
| Gross Margin | 42.05% |
| Net Profit Margin | 27.76% |
| Debt/Equity Ratio | 2.3% |
How did 603235 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield39%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:37 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
JiangXi Tianxin Pharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|